Millendo Therapeutics, Inc. (MLND) financial statements (2020 and earlier)

Company profile

Business Address 110 MILLER AVENUE, SUITE 100
ANN ARBOR, MI 48104
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:6478671141276044
Cash and cash equivalents6273164443618
Short-term investments  5270835426
Other undisclosed cash, cash equivalents, and short-term investments14(0)00(0)(0)
Restricted cash and investments10  0  
Receivables12     
Deferred costs     0 
Assets held-for-sale, not part of disposal group  0  
Other undisclosed current assets5312321
Total current assets:7183691161306245
Noncurrent Assets
Operating lease, right-of-use asset3
Property, plant and equipment  36831
Long-term investments and receivables  00  2
Long-term investments  00  2
Restricted cash and investments 010000
Other noncurrent assets1000 0 
Total noncurrent assets:4146942
TOTAL ASSETS:7584731231396648
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities111081311136
Accounts payable1222332
Accrued liabilities98611884
Employee-related liabilities     31
Debt20     
Other undisclosed current liabilities     (3)(1)
Total current liabilities:131081311106
Noncurrent Liabilities
Long-term debt and lease obligation30     
Long-term debt, excluding current maturities00     
Operating lease, liability2
Liabilities, other than long-term debt0111100
Other liabilities0111100
Total noncurrent liabilities:3111100
Total liabilities:151191412106
Stockholders' equity
Stockholders' equity attributable to parent5971641081275542
Common stock0000000
Additional paid in capital26723536635829515087
Accumulated other comprehensive income (loss)00(0)(0)(0)(0)0
Accumulated deficit(209)(164)(301)(250)(168)(95)(45)
Stockholders' equity attributable to noncontrolling interest12     
Total stockholders' equity:6073641081275542
TOTAL LIABILITIES AND EQUITY:7584731231396648

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues0 010  
Sublease income0
Cost of revenue  (1)(5)(2)  
Gross profit:0 (0)(5)(2)  
Operating expenses(45)(27)(51)(82)(72)(48)(29)
Other undisclosed operating income (loss)(0) 152  
Operating loss:(45)(27)(51)(81)(72)(48)(29)
Nonoperating income (expense)(0) 100(0)0
Investment income, nonoperating(0) 110(0)0
Other nonoperating income (expense)  (0)(0)(0)0 
Interest and debt expense (0)     
Loss from continuing operations before equity method investments, income taxes:(46)(27)(50)(81)(72)(48)(29)
Loss from equity method investments  (1)(2)(2)(2) 
Loss from continuing operations before income taxes:(46)(27)(51)(82)(73)(50)(29)
Income tax expense  (0)(0)(0)  
Loss before gain (loss) on sale of properties:(46)(27)(51)(82)(73)(50)(29)
Other undisclosed net income (loss)1(0)     
Net loss:(45)(27)(51)(82)(73)(50)(29)
Net loss attributable to noncontrolling interest (0)     
Net loss available to common stockholders, diluted:(45)(27)(51)(82)(73)(50)(29)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(45)(27)(51)(82)(73)(50)(29)
Other undisclosed comprehensive income 05182734929
Comprehensive income (loss):(45)(27)00(0)(0)0
Comprehensive loss, net of tax, attributable to noncontrolling interest (0)     
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0 (51)(82)(73)(50)(29)
Comprehensive loss, net of tax, attributable to parent:(45)(27)(51)(82)(73)(50)(29)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: